Taisho Pharmaceutical Holdings Co., Ltd.

OTCPK:TAIS.F Voorraadrapport

Marktkapitalisatie: US$4.6b

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Taisho Pharmaceutical Holdings Toekomstige groei

Future criteriumcontroles 3/6

Taisho Pharmaceutical Holdings is forecast to grow earnings and revenue by 23.7% and 3.2% per annum respectively. EPS is expected to grow by 23.7% per annum. Return on equity is forecast to be 2.8% in 3 years.

Belangrijke informatie

23.7%

Groei van de winst

23.7%

Groei van de winst per aandeel

Pharmaceuticals winstgroei23.7%
Inkomstengroei3.2%
Toekomstig rendement op eigen vermogen2.8%
Dekking van analisten

Low

Laatst bijgewerkt13 Feb 2024

Recente toekomstige groei-updates

Recent updates

Winst- en omzetgroeiprognoses

OTCPK:TAIS.F - Toekomstschattingen van analisten en financiële gegevens uit het verleden (JPY Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
3/31/2027356,30023,800N/AN/A1
3/31/2026329,10018,250N/AN/A2
3/31/2025326,25018,10056,850N/A2
3/31/2024318,5009,30046,380N/A1
12/31/2023320,3858,421N/AN/AN/A
9/30/2023319,96015,570-23,54919,217N/A
6/30/2023313,11417,609N/AN/AN/A
3/31/2023301,38118,997-9,40740,972N/A
12/31/2022295,82125,047N/AN/AN/A
9/30/2022282,56021,0914,27829,052N/A
6/30/2022273,38817,694N/AN/AN/A
3/31/2022268,20313,12214,11728,506N/A
12/31/2021267,7318,055N/AN/AN/A
9/30/2021266,2414,93023,05736,713N/A
6/30/2021270,8418,431N/AN/AN/A
3/31/2021281,98013,31627,65442,026N/A
12/31/2020291,48916,837N/AN/AN/A
9/30/2020302,21916,84627,14538,788N/A
6/30/2020303,29015,589N/AN/AN/A
3/31/2020288,52720,53132,87141,992N/A
12/31/2019272,99315,124N/AN/AN/A
9/30/2019264,26821,13819,81425,986N/A
6/30/2019260,06345,910N/AN/AN/A
3/31/2019261,55148,59314,30819,222N/A
12/31/2018264,19056,614N/AN/AN/A
9/30/2018270,95362,09744,00748,653N/A
6/30/2018273,30839,834N/AN/AN/A
3/31/2018280,09231,67934,83939,852N/A
12/31/2017279,14031,574N/AN/AN/A
9/30/2017277,39627,298N/A29,157N/A
6/30/2017278,87427,370N/AN/AN/A
3/31/2017279,77328,781N/A40,066N/A
12/31/2016281,58827,438N/AN/AN/A
9/30/2016285,15824,691N/A42,280N/A
6/30/2016290,35424,732N/AN/AN/A
3/31/2016290,13522,473N/A43,058N/A
12/31/2015293,71723,594N/AN/AN/A
9/30/2015294,67723,217N/A37,255N/A
6/30/2015291,33922,556N/AN/AN/A
3/31/2015290,49824,529N/A33,715N/A
12/31/2014289,77724,493N/AN/AN/A
9/30/2014293,19928,769N/A44,669N/A
6/30/2014296,15031,940N/AN/AN/A
3/31/2014295,95832,693N/A60,233N/A
12/31/2013292,83832,311N/AN/AN/A
9/30/2013289,77930,170N/A48,360N/A
6/30/2013285,57326,139N/AN/AN/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: TAIS.F's forecast earnings growth (23.7% per year) is above the savings rate (2.3%).

Winst versus markt: TAIS.F's earnings (23.7% per year) are forecast to grow faster than the US market (13.4% per year).

Hoge groeiwinsten: TAIS.F's earnings are expected to grow significantly over the next 3 years.

Omzet versus markt: TAIS.F's revenue (3.2% per year) is forecast to grow slower than the US market (8.2% per year).

Hoge groei-inkomsten: TAIS.F's revenue (3.2% per year) is forecast to grow slower than 20% per year.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: TAIS.F's Return on Equity is forecast to be low in 3 years time (2.8%).

Ontdek groeibedrijven

7D

1Y

7D

1Y

7D

1Y